Jaipur
08042782001
+918824471531
Cardiology by Steris Healthcare Pvt Ltd

Bosentan 125 mg | BOSENTIME 125

INR 750 INR 1265
Phone Number

08042782001

Please keep 0 before dialling the number.

Email Address boost@sterispharma.com

Mon-Thu: 10 AM - 2 PM • Fri: 3 PM - 7AM

Other Website Visit our other website
Address A68-69 Swej Farm Circle, Ram Nagar Extention, Sunder Singh Bhandari Nagar Behind Swej Farm Police Chowki, Sodala

Jaipur, India, 302019

Description

BOSENTIME 125 is a high-quality formulation containing Bosentan 125 mg, an Endothelin Receptor Antagonist (ERA) widely used in the management of Pulmonary Arterial Hypertension (PAH). PAH is a progressive condition characterized by high blood pressure in the arteries of the lungs, leading to shortness of breath, fatigue, and reduced exercise capacity. BOSENTIME 125 works by blocking the action of endothelin-1, a naturally occurring substance that causes blood vessels to constrict. By relaxing the pulmonary blood vessels, BOSENTIME 125 helps reduce the pressure within the lungs, improves oxygen flow, and enhances overall heart and lung function. This medicine is typically used as part of long-term therapy and is recognized for its proven clinical benefits in PAH management. Uses BOSENTIME 125 is primarily prescribed for the following conditions: Pulmonary Arterial Hypertension (PAH): Helps lower blood pressure in the lungs, improving physical capacity and slowing disease progression. WHO Functional Class II–III PAH Patients: Enhances exercise tolerance and reduces PAH-related symptoms. Idiopathic or Heritable PAH: Useful for patients diagnosed without a clear underlying cause. PAH Associated with Connective Tissue Diseases: Provides effective symptom control in conditions like Scleroderma. Vascular Remodeling Management: Helps prevent thickening of blood vessels in the lungs, promoting better long-term outcomes. Benefits BOSENTIME 125 offers several important therapeutic advantages: Improves Exercise Tolerance: Helps patients perform daily activities with less breathlessness and fatigue. Reduces Pulmonary Blood Pressure: Supports better lung-heart circulation by relaxing pulmonary arteries. Slows Disease Progression: Assists in preventing further damage to lung blood vessels when used consistently. Enhances Quality of Life: Reduces chronic symptoms such as chest discomfort, tiredness, and shortness of breath. Works as a Long-Term Therapy: Suitable for chronic management under medical supervision. Can Be Used in Combination Therapy: Often prescribed along with other PAH medicines for enhanced therapeutic effect. Improves Survival Rates in PAH Patients: Due to its effective hemodynamic benefits, it contributes to improved patient outcomes. Dosage The usual recommended dose of BOSENTIME 125 is one tablet twice a day, or as directed by the physician. Treatment often begins with a lower dose, gradually increasing to the therapeutic dose depending on patient tolerance. Tablets should be swallowed whole with water and can be taken with or without food. Do not break, crush, or chew the tablet. Continue treatment regularly, as BOSENTIME 125 is designed for long-term PAH management. Never adjust the dose without consulting your doctor. If a dose is missed, take it as soon as you remember unless it is close to the time for the next dose. Side Effects Like all medicines, BOSENTIME 125 may cause side effects, though not everyone experiences them. Common side effects include: Headache Flushing or warm sensation Swelling of hands, legs, or ankles (fluid retention) Low blood pressure Liver enzyme elevation Nasal congestion Tiredness or weakness Anemia (low red blood cell count) Rare but serious side effects may include: Liver damage Breathing difficulty Severe swelling or rapid weight gain Regular monitoring is essential, especially liver function tests and hemoglobin levels. Precautions and Warning Liver Safety: Bosentan may affect liver function; routine liver function tests are mandatory. Pregnancy Risk: Not recommended during pregnancy; effective contraception is required for women of childbearing age. Heart Conditions: Patients with severe heart problems should use BOSENTIME 125 cautiously. Kidney Impairment: Dose adjustment may be needed for patients with renal issues. Avoid Alcohol: Alcohol can increase the risk of liver-related side effects. Inform your doctor if you have: Liver disease Heart failure Anemia Hypotension Edema Do not combine BOSENTIME 125 with cyclosporine or glyburide due to potential drug interactions. Always use under strict medical supervision. Conclusion BOSENTIME 125 containing Bosentan 125 mg is a vital medication for the long-term management of Pulmonary Arterial Hypertension. By improving blood flow in the lungs, reducing pressure in pulmonary arteries, and enhancing exercise tolerance, it significantly improves a patient’s quality of life. When used consistently under medical supervision, BOSENTIME 125 plays an essential role in slowing PAH progression and optimizing heart-lung function. With proper monitoring and adherence to prescribed dosage, BOSENTIME 125 is a reliable and effective therapeutic option for PAH patients.

Specifications

Active ingredient Bosentan 125 mg
Brand Name BOSENTIME
Manufactured By Steris Healthcare Pvt Ltd
Package SIZE 10x10 Tablets
Dosage As Directed By the Physician
Storage Store In A Cool & Dry Place
Country of origin INDIA

Keywords

Other Medicines

view all

68cd26b4d317e049914de2d3 Card 2

product image
Oncology

Nilotinib is a modern and highly effective targeted therapy used in the treatment of certain types of blood cancer. It belongs to the class of Tyrosine Kinase Inhibitors (TKIs), which work by blocking abnormal signals responsible for uncontrolled cancer cell growth. NILOTHERAPY 150 (Nilotinib 150mg) by Steris Healthcare Pvt. Ltd. is specially formulated to manage Chronic Myeloid Leukemia (CML), a condition caused by the BCR-ABL gene mutation. This medicine is strictly prescription-based and should be taken only under the supervision of a qualified oncologist. Its targeted mechanism makes it a preferred choice in modern cancer therapy, offering improved disease control with better precision compared to traditional chemotherapy. Uses Nilotinib is primarily used for: Treatment of Chronic Myeloid Leukemia (CML) in adults Philadelphia chromosome-positive (Ph+) CML in chronic phase Accelerated phase CML Patients who are resistant or intolerant to first-line therapy such as Imatinib This medicine works by inhibiting the BCR-ABL tyrosine kinase protein, which is responsible for abnormal white blood cell production in CML patients. By blocking this protein, it helps slow or stop the progression of cancer. Benefits NILOTHERAPY 150 (Nilotinib 150mg) offers several important benefits when used under medical supervision: Targeted Action: Directly acts on cancer-causing proteins, reducing damage to healthy cells Better Disease Control: Helps in managing CML more effectively and reducing disease progression Effective in Resistant Cases: Works well in patients who do not respond to earlier treatments Oral Convenience: Easy-to-take tablet form improves patient adherence Long-Term Management: Supports long-term control of chronic myeloid leukemia These advantages make it an important therapy option in oncology treatment protocols. Dosage The dosage of Nilotinib is determined by the doctor based on the patient’s condition and response to treatment. General Guidelines: Usually taken twice daily as prescribed Must be taken on an empty stomach (2 hours after food and 1 hour before next meal) Tablets should be swallowed whole with water; do not crush or chew Important Instructions: Maintain a fixed dosing schedule Avoid grapefruit and grapefruit juice Do not double dose if one is missed Proper adherence is essential for effective results and safety. Side Effects Like all medicines, NILOTHERAPY 150 may cause side effects in some patients. Common Side Effects: Nausea Fatigue Headache Skin rash Muscle pain Constipation or diarrhea Serious Side Effects: Irregular heartbeat (QT prolongation) Liver function abnormalities Severe allergic reactions Unusual bleeding or bruising Pancreatitis Regular medical monitoring helps in early detection and management of these effects. Precautions and Warnings Before using Nilotinib, certain precautions should be followed: Patients with heart conditions should inform their doctor Regular ECG and blood tests are necessary during treatment Blood sugar levels may increase, especially in diabetic patients Liver function should be monitored regularly Avoid use during pregnancy and breastfeeding unless advised by a doctor Inform your doctor about all other medications to avoid interactions Strict adherence to medical supervision ensures safe and effective therapy. Conclusion NILOTHERAPY 150 (Nilotinib 150mg) is a highly advanced targeted therapy used in the management of Chronic Myeloid Leukemia. By specifically inhibiting the BCR-ABL protein, it helps control abnormal cell growth and improves long-term disease outcomes. With its precision-based action, oral convenience, and effectiveness in resistant cases, it plays a vital role in modern oncology treatment. However, it must always be used under strict medical guidance with regular monitoring to ensure safety and best results. Steris Healthcare Pvt. Ltd. continues to provide trusted oncology solutions like NILOTHERAPY 150, supporting patients in their journey toward better health management.